mhurhangee/patent-ind-claim-en huggingface dataset:
Concrete based reinforced road structure covered by asphalt comprising a basic layer made of concrete with a substantially horizontal upper surface and placed directly or through a subconstruction on the ground and at least one mould cover layer thereon made of asphalt, and support elements positioned between the basic layer and the cover layer , characterized in that the support elements are inserted in a predetermined depth in the basic layer prior to the setting thereof so that they are partially projecting out of the basic layer in normal direction to the upper surface, and the projecting portion provides protection to the cover layer against being displaced relative to the basic layer under loads to which the road is exposed, and the support elements are flat stripes with walls being substantially normal to the surface of the basic layer and comprising subsequent sections with differing directions to form respective meandering lines.
Method for manufacturing panels, wherein these panels comprise at least a substrate and a decorative top layer , wherein the aforementioned decorative top layer comprises at least a printed motif and a transparent or translucent protective layer formed there above, and wherein the method comprises at least the following steps: - the step of providing a substrate; - the step (S3) of applying a first finishing layer for forming a first portion of the aforementioned protective layer ; - the step (S7A-S8A) of forming recesses at the surface of the aforementioned first finishing layer ; - the step (S6) of applying a second finishing layer for forming a second portion of the aforementioned protective layer ; - the step of forming recesses at the surface of said second finishing layer , characterized in that the aforementioned first finishing layer comprises hard particles , in that the aforementioned second finishing layer also comprises hard particles, in that the average diameter of the hard particles in said second finishing layer is smaller than the average diameter of the hard particles in the aforementioned first finishing layer and in that the steps of forming recesses comprise at least providing surface structure-altering agents, preferably chemical agents. - the step of providing a substrate; - the step (S3) of applying a first finishing layer for forming a first portion of the aforementioned protective layer ; - the step (S7A-S8A) of forming recesses at the surface of the aforementioned first finishing layer ; - the step (S6) of applying a second finishing layer for forming a second portion of the aforementioned protective layer ; - the step of forming recesses at the surface of said second finishing layer ,
A device for fluid contacting in a downflow vessel, comprising: a liquid collection tray , wherein at least a portion of the liquid collection tray is configured to collect thereon fluids travelling downwardly from a superior catalyst bed ; an enclosed elongate mixing channel , wherein at least a portion of the mixing channel is substantially enclosed such that vapor is maintained within the mixing channel during mixing; a liquid inlet providing fluid communication between the liquid collection tray and the mixing channel , wherein the liquid inlet includes at least one opening in a wall of the mixing channel positioned at a bottom portion of the mixing channel , wherein the at least one opening is positioned at a bottom 50% of the height of the mixing channel ; and a vapor inlet of the mixing channel , downstream of the liquid inlet , configured to pass vapor into the mixing channel , wherein the vapor inlet includes at least two openings of the mixing channel positioned at different heights above the liquid collection tray ; a vapor chimney surrounding the vapor inlet , having a chimney wall extending up from the collection tray and having an upper chimney opening of the vapor chimney at a first height above the liquid collection tray . a liquid collection tray , wherein at least a portion of the liquid collection tray is configured to collect thereon fluids travelling downwardly from a superior catalyst bed ; an enclosed elongate mixing channel , wherein at least a portion of the mixing channel is substantially enclosed such that vapor is maintained within the mixing channel during mixing; a liquid inlet providing fluid communication between the liquid collection tray and the mixing channel , wherein the liquid inlet includes at least one opening in a wall of the mixing channel positioned at a bottom portion of the mixing channel , wherein the at least one opening is positioned at a bottom 50% of the height of the mixing channel ; and a vapor inlet of the mixing channel , downstream of the liquid inlet , configured to pass vapor into the mixing channel , wherein the vapor inlet includes at least two openings of the mixing channel positioned at different heights above the liquid collection tray ; a vapor chimney surrounding the vapor inlet , having a chimney wall extending up from the collection tray and having an upper chimney opening of the vapor chimney at a first height above the liquid collection tray .
A wearable drug delivery device comprising: a housing ; an adhesive layer disposed on an outer surface of the housing for attaching the drug delivery device to a patient's skin; a reservoir ; a volume of a drug product disposed in the reservoir , the drug product comprising a granulocyte colony-stimulating factor (G-CSF); a blunt cannula having a cylindrical wall that defines an axial passage between a first end and a second end of the cannula , the second end of the cannula is connected in fluid communication with the reservoir ; and an introducer needle disposed in the cannula adapted for introducing the cannula into the patient's skin and subsequently withdrawing from the cannula prior to delivery of the drug product to the patient, characterized in that the cannula has at least one side port formed in the wall of the cannula at the first end , and wherein the cannula is initially within the housing and subsequently at least partially deployed from the housing in an operative state. a housing ; an adhesive layer disposed on an outer surface of the housing for attaching the drug delivery device to a patient's skin; a reservoir ; a volume of a drug product disposed in the reservoir , the drug product comprising a granulocyte colony-stimulating factor (G-CSF); a blunt cannula having a cylindrical wall that defines an axial passage between a first end and a second end of the cannula , the second end of the cannula is connected in fluid communication with the reservoir ; and an introducer needle disposed in the cannula adapted for introducing the cannula into the patient's skin and subsequently withdrawing from the cannula prior to delivery of the drug product to the patient, characterized in that the cannula has at least one side port formed in the wall of the cannula at the first end , and wherein the cannula is initially within the housing and subsequently at least partially deployed from the housing in an operative state.
A method of controlling glass temperature in a forehearth that includes at least one burner associated with said forehearth for heating glass in said forehearth, a manifold coupled to said burner, a combustion fuel supply coupled to said burner, a combustion air blower for delivering air under pressure to said manifold, and a cooling air supply communicated with the forehearth, said method including: generating a nominal burner pressure curve as a function of the amount of cooling air provided to the forehearth wherein the pressure curve includes a first portion in which the glass temperature downstream of the burner over a first range of desired temperature conditions is controlled at least in part by adjusting the amount of cooling air provided to the system and the pressure curve includes a second portion in which the temperature downstream of the burner over a second range of desired temperature conditions different from the first range is controlled at least primarily by adjusting the burner pressure; and controlling the burner pressure as a function of current air temperature downstream of said blower and delivered to said manifold according to the nominal burner pressure curve. one burner associated with said forehearth for heating glass in said forehearth, a manifold coupled to said burner, a combustion fuel supply coupled to said burner, a combustion air blower for delivering air under pressure to said manifold, and a cooling air supply communicated with the forehearth, said method including: generating a nominal burner pressure curve as a function of the amount of cooling air provided to the forehearth wherein the pressure curve includes a first portion in which the glass temperature downstream of the burner over a first range of desired temperature conditions is controlled at least in part by adjusting the amount of cooling air provided to the system and the pressure curve includes a second portion in which the temperature downstream of the burner over a second range of desired temperature conditions different from the first range is controlled at least primarily by adjusting the burner pressure; and controlling the burner pressure as a function of current air temperature downstream of said blower and delivered to said manifold according to the nominal burner pressure curve. generating a nominal burner pressure curve as a function of the amount of cooling air provided to the forehearth wherein the pressure curve includes a first portion in which the glass temperature downstream of the burner over a first range of desired temperature conditions is controlled at least in part by adjusting the amount of cooling air provided to the system and the pressure curve includes a second portion in which the temperature downstream of the burner over a second range of desired temperature conditions different from the first range is controlled at least primarily by adjusting the burner pressure; and controlling the burner pressure as a function of current air temperature downstream of said blower and delivered to said manifold according to the nominal burner pressure curve.
An isolated preparation of a mouse monoclonal antibody which specifically binds to a SOX10 protein wherein said mouse monoclonal antibody binds to an epitope in peptide consisting of SEQ ID NO: 3; said mouse monoclonal antibody comprises a light chain variable region comprising the amino acid sequence of SEQ ID NO: 5 and a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 4.
A method of wireless communication of a slave device (706-a), wherein the slave device (706-a) is associated with a first master device and a second master device , wherein the slave device is a user equipment, the first master device includes one of a first macro evolved NodeB, eNB, a first radio resource head, RRH, or a first femto cell, and wherein the second master device includes one of a second eNB, a second RRH, or a second femto cell, the method comprising: receiving , from the first master device , a resource allocation for communicating with the second master device ; determining a type of clear channel assessment, CCA, procedure to perform before communicating with the second master device on an unlicensed channel; performing a CCA procedure to obtain a transmission opportunity based on the determining, the CCA procedure being one of an initial CCA, ICCA, procedure or an extended CCA, ECCA, procedure; and transmitting data to the second master device in accordance with the resource allocation on the unlicensed channel when the transmission opportunity is obtained. receiving , from the first master device , a resource allocation for communicating with the second master device ; determining a type of clear channel assessment, CCA, procedure to perform before communicating with the second master device on an unlicensed channel; performing a CCA procedure to obtain a transmission opportunity based on the determining, the CCA procedure being one of an initial CCA, ICCA, procedure or an extended CCA, ECCA, procedure; and transmitting data to the second master device in accordance with the resource allocation on the unlicensed channel when the transmission opportunity is obtained.
A composition comprising a halogenated volatile compound and hydroxypropyl cellulose (HPC) for topical administration, wherein said halogenated volatile compound is selected from the group consisting of isoflurane, halothane, enflurane, sevoflurane, desflurane, methoxyflurane, and any mixture thereof.
A method of transmitting data from a lower-layer split central unit, LLS-CU, to a radio unit, RU, in a network node of a wireless communication system for transmission by the RU over a wireless interface, the method comprising: mapping , at the LLS-CU, user data and a plurality of reference symbols to be transmitted with the user data by the RU to resource elements to provide mapped data; compressing the mapped data including the plurality of reference symbols using a bitmap representation of the mapped data to obtain compressed data; transmitting the bitmap representation from the LLS-CU to the RU; and transmitting the compressed data from the LLS-CU to the RU. mapping , at the LLS-CU, user data and a plurality of reference symbols to be transmitted with the user data by the RU to resource elements to provide mapped data; compressing the mapped data including the plurality of reference symbols using a bitmap representation of the mapped data to obtain compressed data; transmitting the bitmap representation from the LLS-CU to the RU; and transmitting the compressed data from the LLS-CU to the RU.
A magnetic measurement method characterized by the measurement of magnetic characteristic of a sample of 50 nm in thickness by irradiating the sample with X-rays and detecting X-rays passing the sample, wherein circular polarization X-rays focused into 10 nm in beam size are used, wherein while the sample is placed within an applied external magnetic field, the sample is alternately irradiated with right-circular polarization X-rays and left-circular polarization X-rays, absorption of both right-circular and left-circular polarization X-rays is measured, respectively, and the difference between the two X-ray absorptions, i.e. X-ray magnetic circular dichroism, is detected, or while the sample is placed within an applied external magnetic field, X-ray absorption of the sample parallel to the magnetic field direction and X-ray absorption of the sample anti-parallel to the magnetic field direction are measured, respectively, and the difference between said two X-ray absorptions is detected. while the sample is placed within an applied external magnetic field, the sample is alternately irradiated with right-circular polarization X-rays and left-circular polarization X-rays, absorption of both right-circular and left-circular polarization X-rays is measured, respectively, and the difference between the two X-ray absorptions, i.e. X-ray magnetic circular dichroism, is detected, or while the sample is placed within an applied external magnetic field, X-ray absorption of the sample parallel to the magnetic field direction and X-ray absorption of the sample anti-parallel to the magnetic field direction are measured, respectively, and the difference between said two X-ray absorptions is detected.
A compound represented by Formula (I'): wherein the combination (m, n) is selected from , , , , , and ; R 1 represents a hydrogen atom, a hydrocarbon group optionally having a substituent(s), a heterocyclic group optionally having a substituent(s), or an amino group optionally having a substituent(s); R 2 represents a polycyclic aryl group optionally having a substituent(s), a heterocyclic group optionally having a substituent(s), an aryloxy group optionally having a substituent(s), a phenyl group having a substituent(s), an aralkyl group having a substituent(s), or a group represented by the following Formula (II): wherein Ring A and Ring B each represent a monocyclic or polycyclic aryl group or heterocyclic group optionally having a substituent(s); R 4 represents a single bond, a C 1-3 alkylene group optionally having a substituent(s), a C 2-3 alkenylene group optionally having a substituent(s), or a divalent oxy group; and the Ring A, Ring B, or R 4 moiety is linked to X; R 3 represents 0 to 7 substituent(s) linked to the naphthyl group, each of which substituent(s) is the same or different and has 1 to 10 atoms; and X represents a single bond, a C 1-6 alkylene group optionally having a substituent(s), a C 2-6 alkenylene group optionally having a substituent(s), an -R 5 -NH-group, an -NH-R 5 - group wherein R 5 represents a C 1-5 alkylene group optionally having a substituent(s), or a C 2-5 alkenylene group optionally having a substituent(s), or a secondary or tertiary amino group or a salt thereof. the combination (m, n) is selected from , , , , , and ; R 1 represents a hydrogen atom, a hydrocarbon group optionally having a substituent(s), a heterocyclic group optionally having a substituent(s), or an amino group optionally having a substituent(s); R 2 represents a polycyclic aryl group optionally having a substituent(s), a heterocyclic group optionally having a substituent(s), an aryloxy group optionally having a substituent(s), a phenyl group having a substituent(s), an aralkyl group having a substituent(s), or a group represented by the following Formula (II): wherein Ring A and Ring B each represent a monocyclic or polycyclic aryl group or heterocyclic group optionally having a substituent(s); R 4 represents a single bond, a C 1-3 alkylene group optionally having a substituent(s), a C 2-3 alkenylene group optionally having a substituent(s), or a divalent oxy group; and the Ring A, Ring B, or R 4 moiety is linked to X; R 3 represents 0 to 7 substituent(s) linked to the naphthyl group, each of which substituent(s) is the same or different and has 1 to 10 atoms; and X represents a single bond, a C 1-6 alkylene group optionally having a substituent(s), a C 2-6 alkenylene group optionally having a substituent(s), an -R 5 -NH-group, an -NH-R 5 - group wherein R 5 represents a C 1-5 alkylene group optionally having a substituent(s), or a C 2-5 alkenylene group optionally having a substituent(s), or a secondary or tertiary amino group
A catalyst for the oxidation of SO 2 to SO 3 , obtained from at least two different naturally occurring diatomaceous earths having a content of cristobalite of < 5% by weight and from vanadium compounds, alkali metal compounds and sulfate, wherein the at least two different naturally occurring diatomaceous earths originate from different geographic deposits and differ in the structure type of the siliceous algae from which they are derived.
A beam coupling device comprising: a light source that includes a plurality of light emitters arranged as a set of light emitters in a first direction (X) and arranged as a plurality of sets of light emitters in a second direction, to emit a plurality of light beams having a light ray direction (La) from each of the light emitters , wherein the first direction (X) and the second direction (Y) intersect each other and the light ray direction (La) intersects the first and second directions; a plurality of optical units (4-1 to 4-3) arranged to guide each light beam for each set of light emitters arranged in the first direction (X) in the light source ; and a coupling optical system arranged to couple the plurality of light beams guided by each of the optical units, wherein each of the optical units is arranged to direct outward the light ray direction (La) of a first light beam among light beams emitted by the set of light emitters , to guide the light beams from the set of light emitters into the coupling optical system , the first light beam being emitted by a light emitter that is located outside in the first direction (X) for the set of light emitters . a light source that includes a plurality of light emitters arranged as a set of light emitters in a first direction (X) and arranged as a plurality of sets of light emitters in a second direction, to emit a plurality of light beams having a light ray direction (La) from each of the light emitters , wherein the first direction (X) and the second direction (Y) intersect each other and the light ray direction (La) intersects the first and second directions; a plurality of optical units (4-1 to 4-3) arranged to guide each light beam for each set of light emitters arranged in the first direction (X) in the light source ; and a coupling optical system arranged to couple the plurality of light beams guided by each of the optical units, wherein each of the optical units is arranged to direct outward the light ray direction (La) of a first light beam among light beams emitted by the set of light emitters , to guide the light beams from the set of light emitters into the coupling optical system , the first light beam being emitted by a light emitter that is located outside in the first direction (X) for the set of light emitters .
A sensor molecule for detecting lactose or lactulose comprising a bacterial BgaR transcription factor, or variant thereof that has an amino acid sequence which is at least 80% identical to that provided in SEQ ID NO: 1, covalently joined to a resonance energy transfer donor domain and a resonance energy transfer acceptor domain, wherein the spatial location and/or dipole orientation of the donor domain relative to the acceptor domain is altered when lactose or lactulose binds to the transcription factor.
A thermoplastic resin composition comprising: 100 parts by weight of a polyolefin resin comprising at least one of a polypropylene resin and an ethylene-propylene block copolymer; 10 parts by weight to 60 parts by weight of a phosphorus nitrogen-based flame retardant; 0.05 parts by weight to 10 parts by weight of a maleic anhydride-modified olefin polymer; and 5 parts by weight to 40 parts by weight of talc having a calcium content of 0.1 wt% or less, as determined by ICP inorganic analysis. 100 parts by weight of a polyolefin resin comprising at least one of a polypropylene resin and an ethylene-propylene block copolymer; 10 parts by weight to 60 parts by weight of a phosphorus nitrogen-based flame retardant; 0.05 parts by weight to 10 parts by weight of a maleic anhydride-modified olefin polymer; and 5 parts by weight to 40 parts by weight of talc having a calcium content of 0.1 wt% or less, as determined by ICP inorganic analysis.
A lubricant composition comprising a base oil of lubricating viscosity; nitrogen provided by a dispersant system and an antioxidant system; the dispersant system consisting of at least one hydrocarbyl substituted succinimide dispersant obtainable by reacting a hydrocarbyl substituted acylating agent with a nitrogen source; the antioxidant system consisting of at least one aminic antioxidant selected from an aromatic amine, an alkylated diphenylamine, a phenyl-α-napthylamine, alkylated phenyl-α-naphthylamines, hindered non-aromatic amines, or combinations thereof and, optionally, further antioxidant selected from a phenolic antioxidant, a sulfurized olefin, aminic antioxidants, or combinations thereof; a weight ratio of nitrogen provided by the dispersant system to total nitrogen in the lubricant composition of 0.6:1 to 0.85:1; and at least 75% of the nitrogen provided by the dispersant system is a primary or secondary nitrogen and not post-reacted. a base oil of lubricating viscosity; nitrogen provided by a dispersant system and an antioxidant system; the dispersant system consisting of at least one hydrocarbyl substituted succinimide dispersant obtainable by reacting a hydrocarbyl substituted acylating agent with a nitrogen source; the antioxidant system consisting of at least one aminic antioxidant selected from an aromatic amine, an alkylated diphenylamine, a phenyl-α-napthylamine, alkylated phenyl-α-naphthylamines, hindered non-aromatic amines, or combinations thereof and, optionally, further antioxidant selected from a phenolic antioxidant, a sulfurized olefin, aminic antioxidants, or combinations thereof; a weight ratio of nitrogen provided by the dispersant system to total nitrogen in the lubricant composition of 0.6:1 to 0.85:1; and